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High magnesium concentration inhibits the effect of arginine vaso-
pressin (AVP) on smooth muscle contraction and platelet aggregation
and also influences hepatocyte AVP receptor binding. The aim of this
study was to determine the role of magnesium concentration [Mg2+] in
AVP-stimulated water transport in the kidney collecting duct. The
effect of low and high peritubular [Mg2+] on the AVP-stimulated
osmotic water permeability coefficient (Pf) was evaluated in the
isolated perfused rabbit cortical collecting duct (CCD). Control tu-
bules bathed and perfused with standard Ringer bicarbonate solution
containing 1 mM Mg2+ presented a Pf of 223.9 ± 27.2 µm/s. When
Mg2+ was not added to the bathing solution, an increase in the AVP-
stimulated Pf to 363.1 ± 57.2 µm/s (P<0.05) was observed. An eleva-
tion of Mg2+ to 5 mM resulted in a decrease in Pf to 202.9 ± 12.6 µm/
s (P<0.05). This decrease in the AVP-stimulated Pf at 5 mM Mg2+
persisted when the CCDs were returned to 1 mM Mg2+, Pf = 130.2 ±
20.3 µm/s, and was not normalized by the addition of 8-[4-chlorophe-
nylthio]-adenosine 3',5'-cyclic monophosphate, a cAMP analogue, to
the preparation. These data indicate that magnesium may play a
modulatory role in the action of AVP on CCD osmotic water perme-
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The collecting duct, as the final portion
of the nephron, plays an important role in the
control of the extracellular water and salt
balance. During water deprivation or extra-
cellular volume contraction, increases in va-
sopressin release elicit a rise in osmotic wa-
ter permeability in the kidney collecting ducts.
The effect of vasopressin on water reabsorp-
tion in the collecting duct is mediated through
the classic second messenger adenosine 3',5'-
cyclic monophosphate (cAMP) via V2 recep-
tors. The increase in cyclic AMP levels in the
cell leads to the activation of protein kinase
A, which promotes the phosphorylation and
trafficking of water channels, i.e., the aqua-
porin-2 protein, from the intracellular vesicles
to the plasma membrane (1,2).
The hormone arginine vasopressin (AVP)
has multiple functions in the organism, in-
cluding the stimulation of kidney antidiure-
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sis, the contraction of smooth muscle, plate-
let aggregation, stimulation of liver glyco-
genolysis, and the modulation of adrenocor-
ticotropic hormone release from the pitu-
itary (3).
The regulatory role of intracellular cal-
cium concentration [Ca2+] during AVP stim-
ulation of water reabsorption in the collect-
ing ducts is a well-known event. Calcium
controls the activation or inhibition of the
intracellular signaling pathways that are in-
volved in the water channel insertion into the
apical membrane (1,4). In the collecting
ducts, high or low intracellular [Ca2+]i has an
inhibitory effect on the AVP-stimulated wa-
ter hydroosmotic response (4,5). In contrast,
the role of the cation magnesium (Mg2+) in
the action of AVP on renal epithelia is not
clear. It is well established that extracellular
Mg2+ has inhibitory effects on AVP-stimu-
lated Ca2+ influx in smooth muscle cells and
inhibits AVP receptor binding in platelets
and hepatocyte membranes (6,7). Little is
known about the effect of [Mg2+] on AVP-
stimulated water reabsorption in the collect-
ing duct. Argy et al. (8) have already ob-
served that the addition of 8 mM Mg2+ to the
serosal surface of the toad bladder inhibits
AVP stimulation of the osmotic water flow
and urea permeability.
The use of magnesium supplements in
several therapies is increasing. High doses
of magnesium are used clinically for the
prevention or improvement of several disor-
ders and in the composition of organ preser-
vation solutions. One of the main roles at-
tributed to magnesium in these therapies is
its action as a calcium blocker in several
tissues (9). Therefore, it would be interesting
to know the effect of high extracellular Mg2+
concentrations on the AVP-stimulated hy-
droosmotic response of renal epithelia.
The objective of the present study was to
examine the effects of extracellular magne-
sium depletion or increase on the AVP-stim-
ulated osmotic water permeability coeffi-
cient in isolated perfused rabbit cortical col-
lecting ducts (CCDs).
In vitro isolated rabbit CCDs were per-
fused by the method of Burg et al. (10) and as
previously reported by our group (11).
Briefly, New Zealand white rabbits weigh-
ing 1.0-2.0 kg were killed by cervical dislo-
cation and the kidneys were immediately
removed. Thin coronal slices of the kidney
were placed in chilled (10oC) and oxygen-
ated Ringer bicarbonate  (Rb) solution for
tubule dissection. Isolated CCDs (1-2.5 mm)
were transferred to a controlled temperature
Lucite chamber mounted on the stage of an
inverted microscope (Reichert, Biostar,
Vienna, Austria). The tubules were connected
to a concentric glass pipette system. The
CCDs were perfused at a flow rate of 15 to
20 nl/min obtained by hydrostatic pressure
applied to the perfusion pipette. The bathing
solution was heated and maintained at 37oC
with a thermistor and exchanged continu-
ously at a rate of 0.3 ml/min.
The tubules were dissected and bathed in
modified Ringer solution containing 105 mM
NaCl, 25 mM NaHCO3, 10 mM Na acetate,
2.3 mM NaH2PO4, 5 mM KCl, 1.8 mM
CaCl2, 1 mM MgSO4, 8.3 mM glucose, 5
mM alanine. The osmolality of this solution
was 286 ± 4 mOsm/kg H2O and the pH was
adjusted to 7.4 by bubbling with a 95% O2
and 5% CO2 gas mixture. The perfusion
solution consisted of hypotonic Ringer bi-
carbonate of the same composition as the
bathing solution, except for NaCl, which
was reduced to 15 mM. The perfusate pre-
sented an osmolality of 126 ± 5 mOsm/kg
H2O. A tracer amount of [Carboxy-14C] inu-
lin (New England Nuclear, Boston, MA), 5
µCi/ml, was added to the perfusate as a
volume marker.
The transepithelial osmotic water perme-
ability coefficient Pf (µm/s) was computed
from lumen to bath osmotic volume flow
according to the equation (12):
Pf = (1/AVwCb2){Cb(Vi - Vo) + CiVi
[ln (Cb - Ci)Vi - ln (CbVo - CiVi)]}
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where Vi is the perfusion rate in cm/s, calcu-
lated from the collection rate (Vo) and the
rate of 14C-inulin in the perfused and col-
lected fluid, according to Vi = Vo(14C-inulin
collected/14C-inulin perfused); A is the sur-
face area (cm2), calculated from the length of
the tubule, measured with an eyepiece reti-
cule, and an assumed internal diameter of 20
µm; Vw is the partial molar volume of water
(cm3/mmol), and Ci and Cb are the osmotic
concentrations of the perfusate and bathing
medium, respectively.
Four groups of experiments were per-
formed. Each experimental protocol started
after a 60-min period of equilibration at
37oC following the initiation of perfusion. A
30-min basal period was allowed to elapse,
after which the tubules were bathed during
the experimental period with Ringer bicar-
bonate solution containing different MgSO4
concentrations and stimulated with 230 pM
AVP or 10-4 M cAMP (8-[4-chlorophe-
nylthio]-adenosine-3',5'-cyclic monophos-
phate, Sigma Chemical Co., St. Louis, MO)
for Pf evaluation. Thereafter, the bathing
solution was replaced with Rb solution con-
taining 1 mM MgSO4 for 30 min to remove
AVP. During the recovery period, the tu-
bules were bathed with 1 mM MgSO4 Rb
plus AVP or cAMP.
The data are reported as the mean ± SEM
of individual values for each tubule, which
represent the means of 3 to 4 collections per
period. Statistical significance was evalu-
ated at the 95% confidence level. Intergroup
one-way analysis of variance (ANOVA) and
the screening Bonferroni t-test were used.
The paired Stundent t-test was employed for
analysis of the differences between the ex-
perimental and recovery periods.
The Pf data for the CCDs during the
basal, experimental and recovery periods are
presented in Table 1. When the magnesium
was omitted from the Rb solution during the
experimental period, a significant elevation
(P<0.05) of the AVP-elicited Pf to 363.1 ±
57.2 µm/s was observed, in relation to the
control group. This increase in osmotic wa-
ter permeability persisted after the addition
of 1 mM Mg2+ to the Rb solution (Pf of 371.0
± 67.9 µm/s), during the recovery period.
The control group bathed with 1 mM Rb
Mg2+ showed a Pf of 223.9 ± 27.2 µm/s.
When the CCDs were incubated in 5 mM Rb
Mg2+ a slight decrease in Pf to 202.9 ± 12.6
µm/s was noted. During the recovery period,
these tubules presented a greater decrease of
the AVP-stimulated Pf to 130.2 ± 20.3 µm/s
(P<0.05), resulting in an inhibition of 38 ±
10% of the Pf response (Figure 1). This
decrease in the stimulated hydroosmotic re-
sponse was not reversed by the replacement
Table 1 - Effect of increasing [Mg2+] on the AVP- or cAMP-stimulated osmotic water permeability response.
The number of experiments is given in parentheses and the results are reported as the means ± SEM for the
basal, experimental (Exp) and recovery (Rec) periods. *P<0.05 for experimental x recovery period. aP<0.05
experimental 0 mM ¹ 1 and 5 mM/AVP; bP<0.05 recovery 0 mM ¹ 1 and 5 mM/AVP and cAMP (ANOVA
followed by the Bonferroni t-test). Vo: Perfusion flow rate; Pf: osmotic water permeability coefficient; AVP:
arginine vasopressin; cAMP: adenosine 3',5'-cyclic monophosphate; [Mg2+]: magnesium concentration.
 Group/ Vo (nl/min) Pf (µm/s)
[Mg2+](mM)
Basal Exp Rec Basal Exp Rec
AVP/0 (5) 18.3 ± 2.6 22.1 ± 0.9 22.1 ± 1.8 71.7 ± 39.2 363.1 ± 57.2 371.0 ± 67.9
AVP/1 (8) 19.1 ± 1.1 20.7 ± 0.7 20.3 ± 0.9 48.7 ± 17.2 223.9 ± 27.2a 198.6 ± 42.5b
AVP/5 (5) 15.9 ± 0.6 18.1 ± 1.5 17.4 ± 0.2 35.1 ± 9.2 202.9 ± 12.6a 130.2 ± 20.3*b
cAMP/5 (4) 14.0 ± 0.6 18.4 ± 0.3 16.9 ± 1.4 29.4 ± 19.3 224.7 ± 33.9 105.4 ± 11.4*b
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of AVP with the cAMP analogue and re-
sulted in an inhibition of Pf of 51 ± 8%
(P<0.05) between the recovery and the ex-
perimental periods (Figure 1). In the control
group, in which no variation in [Mg2+] oc-
curred between the experimental and the
recovery period, only a 14 ± 9% inhibition of
Pf was noted after two consecutive AVP
doses.
These data demonstrate that the AVP-
stimulated osmotic water permeability of
cortical collecting ducts could be modulated
by extracellular magnesium concentration,
as is the case for the action of AVP on the
smooth muscle contraction response.
The present study demonstrates the im-
portance of extracellular magnesium con-
centration in kidney epithelial ADH-depend-
ent water transport. Under our experimental
conditions, cortical collecting ducts submit-
ted to reduced peritubular [Mg2+] displayed
an increase in the AVP-stimulated osmotic
water permeability coefficient.
In the rat vascular smooth muscle cells
(VSMC), AVP stimulation through V1 re-
ceptors induces the mobilization of intracel-
lular [Mg2+]i and cytosolic free [Ca2+]i in a
dose-dependent manner (6,7). In these cells,
it was also observed that the removal of
extracellular Mg2+ enhanced the AVP-mobi-
lized [Ca2+]i but not [Mg2+]i (6). On the other
hand, studies with VSMC have demonstrated
that high extracellular [Mg2+] suppressed the
activation of a non-selective cation current
of Ca2+ induced by AVP-stimulation (13).
Similarly, in human myometrial cells a high
extracellular magnesium concentration re-
duces the intracellular free [Ca2+] induced
by oxytocin (14). If these mechanisms are
also present in the CCD epithelial cells, it
would be expected that elevated extracellu-
lar [Mg+] would decrease cytosolic free Ca2+
concentration, which would have an inhibi-
tory effect on the AVP-stimulated hydroos-
motic response (5). In agreement with this
hypothesis, under our experimental condi-
tions CCDs incubated in 5 mM Mg2+ solu-
tion showed a fall in AVP- and cAMP-stim-
ulated water osmotic permeability in com-
parison to tubules incubated in the absence
of Mg2+.
The effects of magnesium concentration
on the action of other hormones and AVP-
related systems have been reported in the
literature. AVP release from nerve endings
in the neurohypophysis is controlled by the
[Mg2+] (15); platelet formation of inositol
triphosphate depends on [Mg2+] (16). In-
creases in [Mg2+] also inhibit the PTH stim-
ulation of cAMP production in renal cortical
slices (17).
Our data suggest that a high magnesium
concentration inhibits AVP-stimulated hy-
droosmotic permeability. This decrease in
AVP response persisted after the tubules
were returned to normal Ringer bicarbonate
solution containing 1 mM Mg2+, showing a
continued inhibitory response. This inhibi-
tion was not reversed by the addition of the
cAMP-analogue to the preparation, indicat-
ing that extracellular magnesium probably
acts on a level beyond the second messenger
for the insertion of the aquaporin-2 protein
in the apical membrane.
It is also possible that there is an in-
creased binding affinity of AVP for its re-
ceptor, contributing to an enhanced response
and/or receptor and cAMP desensitization
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Figure 1 - Inhibitory effect of high
magnesium concentrations on
AVP or adenosine 3',5'-cyclic
monophosphate (cAMP)-stimu-
lated osmotic water permeabil-
ity coefficient (Pf), in the recov-
ery period. The Pf inhibition rate
was calculated as: [(Pfexperi-
mental - Pfrecovery)/Pfexperi-
mental] x 100. Data are reported
as mean ± SEM. *P<0.05, 0 mM
¹ 5 mM and 5 mM Mg2+ plus
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studies on other tissues reporting that extra-
cellular Mg2+ enhanced vasopressin binding
to its receptors in the pig kidney epithelial
cell line LLC-PK1, in intact platelets and in
rat liver membranes (16,18,20). Several stud-
ies have demonstrated that high doses of
AVP decrease water osmotic permeability
and cAMP production by activating inhibi-
tory G proteins, prostaglandin production,
the rise in intracellular Ca2+, the increase in
cGMP and/or the stimulation of the protein
kinase C (3,19-21).
Finally, the conclusion that a high extra-
cellular magnesium concentration inhibits
the AVP-stimulated osmotic water perme-
ability in the cortical collecting ducts needs
further study to determine the pathway that
is implicated in this mechanism.
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